Pioglitazone
Pioglitazone is an active ingredient of the class «2,4-thiazolidinedione».
Group of stereoisomers
Boxed warning (US label)
Congestive heart failure. CONGESTIVE HEART FAILURE • Thiazolidinediones, including ACTOS ®, cause or exacerbate congestive heart failure in some patients. • After initiation of ACTOS, and after dose increases, monitor patients carefully for signs and symptoms of heart failure (e.g.…
What it is used for
- Maturity-onset diabetes of the young type 2
- Diabetes
- Type 2 diabetes
Monotherapy and Combination Therapy ACTOS is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings.
Pioglitazone is indicated in the treatment of type-2 diabetes mellitus: as monotherapy: in patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance; as dual oral…
How it works
- Peroxisome proliferator-activated receptor gamma agonist
Class: 2,4-thiazolidinedione
Common side effects
The following serious adverse reactions are discussed elsewhere in the labeling: • Congestive heart failure • Edema • Fractures Most common adverse reactions (≥5%) are upper respiratory tract infection, headache, sinusitis, myalgia, and pharyngitis.
Who should not take it
Initiation in patients with established NYHA Class III or IV heart failure. • Use in patients with known hypersensitivity to pioglitazone or any other component of ACTOS. • Initiation in patients with established New York Heart Association (NYHA) Class III…
Pregnancy and breastfeeding
Limited data with ACTOS in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. There are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy.
Interactions
Brand names
United States
Actos
European Union
Actos · Pioglitazone Accord · Pioglitazone Actavis
Canada
Ag-Pioglitazone · Jamp Pioglitazone · Mint-Pioglitazone · Teva-Pioglitazone
Other trade names
Diabiom · Glidipion · Glidipion (previously pioglitazone actavis group) · Glizofar · Glustin · Paglitaz · Pioglitazone krka · Pioglitazone teva · Pioglitazone teva pharma · Poze · Sepioglin
Approval status
- US Food and Drug Administration
- prescription · since 1999
- European Medicines Agency
- authorised · since 2000
- Health Canada
- prescription · marketed
- First approval anywhere
- 1999
Codes
- ATC
- A10BG03
- RxNorm CUI
- 33738
- ChEMBL
- CHEMBL595
- PubChem CID
- 4829
- UNII
- X4OV71U42S
- Wikidata
- Q417765
Frequently asked questions
What is Pioglitazone used for?
Pioglitazone is used for: Maturity-onset diabetes of the young type 2, Diabetes, and Type 2 diabetes.
What kind of medicine is Pioglitazone?
Pioglitazone is an active ingredient of the class «2,4-thiazolidinedione».
What are the brand names of Pioglitazone?
Brand names of Pioglitazone include Actos, Pioglitazone Accord, Pioglitazone Actavis, Ag-Pioglitazone, Jamp Pioglitazone, Mint-Pioglitazone, Teva-Pioglitazone, and Diabiom.
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)